Background: Smooth muscle cells (SMCs) in the tunica media of the saphenous vein (SV) used for aortocoronary grafts play a key role in intimal hyperplasia. This process, followed by the development of atherosclerosis, leads to occlusion of the SV grafts months and years after coronary artery bypass grafting (CABG). Caveolins have been suggested to control some of the SMCs responses. The aim of this study was to identify any variations in expression of caveolins (cav-1, cav-2 and cav-3) in the SMCs of the SV transplants in relation to the age of CABG who undergo CABG.
INTRODUCTION
An interposition of the saphenous vein (SV) between the aorta and the recipient coronary arteries during coronary artery bypass grafting (CABG) initiates a series of biological events within the venous wall. The formation of neointima serves as the foundation for subsequent progressive occluding graft atheroma [1, 2] . Patency of the grafts is considered a critical determinant of CABG long-term outcomes. Phenotypic transformation of the smooth muscle cells (SMCs) in the tunica media of the SV grafts followed by abnormal proliferation and migration through internal elastic lamina, are key factors in neointima development [3, 4] . SMCs respond to a variety of biologically active molecules released by the injured endothelium, platelets and activated macrophages [5, 6] . A number of studies have demonstrated that cellular SMCs response is mediated by specialized 50 -100 nm flaskshape plasma membrane invaginations known as caveolae [7, 8] . The major protein caveolar *Address correspondence to this author at the Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences in Poznan, Ul. Dluga1/2, 61-848 Poznan, Poland; Tel/Fax: +48 61 8549085; E-mail: bperek@yahoo.com components are caveolins. Currently, three different types have been identified: caveolin-1 (cav-1), caveolin-2 (cav-2), and caveolin-3 (cav-3) [9] [10] [11] . Cav-1 has been suggested to inhibit proliferative responses of the SMCs to platelet-derived growth factor (PDGF) [12, 13] . PDGF and basic fibroblast growth factor that are able to induce SMCs stimulation, decreases with age [14] . Notably, elderly individuals constitute a constantly increasing population of patients undergoing CABG [15] .
Thus, the aim of this study was to identify any variations in expression of cav-1, cav-2 and cav-3 in the SMCs of the SV transplants in relation to the age of CABG patients.
MATERIAL AND METHODS

Study Group
Institutional Review Board at Poznan University of Medical Sciences approved a research protocol (Approval No.1201/08). An informed written consent from each study participant was obtained. One hundred ten consecutive patients (83 males and 27 females with the age ranging from 46 to 85 years) who underwent isolated non-emergent CABG with the use of at least one aortocoronary bypass graft between November 2008 and February 2009 were enrolled in the study. They were retrospectively divided into four subgroups according to the age at the time of surgery: (A; n=19) 50 year-old, (B; n=24) >50 and 60 year-old, (C; n=40) >60 and 70 year-old, (D; n=27) >70 year-old. The most important preoperative demographics and clinical history data are summarized in Table 1 .
Operation Procedure and Sample Collection
All surgeries were performed from median sternotomy. A part of them were carried out on the beating heart (OPCAB, off-pump coronary artery bypass) and the others in the extracorporeal circulation (CCAB, conventional coronary artery bypass). The studied age-matched subgroups did not differ with respect to surgical technique of CABG (OPCAB vs. CCAB), a number and type of the aortocoronary grafts (arterial vs. venous), and the rate of complete revascularization. Some intra-operative data are presented in Table 2 .
SV was harvested using continuous leg incision over its course with the use of "no-touch" technique. The most distal part of the harvested SV segments (at least 1.5 -2 cm long) were saved for immunohistochemical examinations. These samples were carefully rinsed with 0.9% NaCl at the room temperature, fixed in the freshly prepared Bouin's solution. Then the samples were transferred to the (8) 4 (10) 3 (11) *p<0.05 group A vs group D; BMI = body mass index; CAD = coronary artery disease; PCI = percutaneous coronary intervention; PVD = peripheral vascular disease. ns; a all severely stenotic or occluded coronary arteries were bypassed. Abbreviations: CCAB = conventional coronary artery bypass (in the extracorporeal circulation); LITA = left internal thoracic artery; OPCAB = off-pump coronary artery bypass; RA = radial artery; RITA = right internal thoracic artery.
Department of Histology and Embryology, where they were embedded in paraffin and cut into 5-6 m thin sections on a semi-automatic rotary microtome (Leica RM 2145, Leica Microsystems, Nussloch, Germany).
Immunohistochemical Analysis
The immunohistochemical analysis employed StreptABComplex/HRP method modified by biotinylated tyramine (Dako Catalysed Signal Amplification System, Peroxidase, K1500, Dako Denmark A/S, Glostrup, Denmark) [16] . In marker detection, the chromogen reaction was developed using 0.5% 3-3' diaminobenzidine (Sigma Chemical Co., St. Louis, MO) in TRIS/HCl, pH 7.6 plus 0.3% H 2 O 2 .
Following monoclonal mouse anti-human antibodies were used: anti-cav-1 (diluted 1:300, NB100-615, Novus Biologicals, Cambridge, GB), anti-cav-2 (diluted 1:100, sc-7942, Santa Cruz Biotechnology, Heidelberg, Germany) and anti-cav-3 (diluted 1:500, NB100-5029, Novus Biologicals).
The intensity of the immunostaining was quantified using the computer software AxioVisionLE for Windows ver.4.8.2 on the images of the SV samples captured with an AxioCam MRc5 digital camera attached to an AxioImager Z.1 light microscope (Carl Zeiss MicroImaging GmbH, Göttingen, Germany). Tissue expression was evaluated semi-quantitatively employing the following classification, where (0) meant no immunoreactivity; (1+) -up to 25%; (2+) -between 26% and 50% and (3+) -more than 50% of the immunostained tunica media.
All the immunohistochemical analyses were performed blind by two experienced pathologists on coded samples and complied with the principles of positive and negative controls. Median values of 10 representative microscopic fields (double analysis) located evenly around the vessel wall circumference were entered into further calculations and statistical analyses. The negative controls were performed using normal mouse IgG antibodies or phosphate buffered solution. In addition, the serial sections were stained in the subsequent experiments as positive controls to determine the consistency of staining.
Data Management and Statistical Analysis
Initially, all continuous variables were estimated for normality with the Shapiro-Wilk W test. When they complied with a normal distribution they were expressed as mean ± standard deviation. The Nominal data (ie. semi-quantitative caveolin expression) were compared with the use of a Kruskal-Wallis test for multiple rang comparisons. Correlations between the patient age and expression of caveolins were tested with the use of a non-parametric R Spearmann correlation test. A p value < 0.05 was regarded as statistically significant. Analyses were carried out using Statistica 9.0 for Windows (StatSoft, Inc., Tulsa, OK, USA).
RESULTS
Expression of either cav-1 or cav-3 in the tunica media of the SV segments was detected in the samples obtained from all patients. Cav-1 expression increased systematically with the age of CABG patients (subgroup A < subgroup B < subgroup C < subgroup D; p<0.05) (Figure 1) . The significant differences in the Kruskal-Wallis test were found between groups A and D (p = 0.015), and between groups A and C (p = 0.007) (Figure 2) . Statistical analysis also confirmed significant positive correlation between the age of CABG patients and cav-1 expression (r=0.450; p<0.001).
Cav-2 expression in the media of the SV did not differ significantly between examined subgroups of age-matched CABG patients. Contrary to the other caveolins, in some SV segments no cav-2 expression was found. The rate of cav-2-negative SV segments ranged from 25% (subgroup B) to 47% (subgroup A).
Cav-3 expression in the SV media increased with the age of CABG patients (p=0.0005 in Kruskal-Wallis test) (group A < group B < group C < group D) and differed significantly between groups A and D (p= 0.002), and between groups A and C (p= 0.015) (Figure 3) . Correlation analysis revealed a positive significant association between the age of patients undergoing CABG and the expression of cav-3 (r=0.463; p<0.001; Figure 4) .
DISCUSSION
Neointima formation in the SV aortocoronary grafts' wall followed by its hyperplasia is considered a physiological reaction to high pressure, high stretch forces, and abnormal shear stresses [3, 4] . Unfortunately, it facilitates the development of atheroma that many months and years later may lead to severe stenosis and occlusion of the grafts [2] . Venous SMCs, as the main effector cells of venous graft disease, are not a homogenous cell population and are characterized by variable ability to react to a variety of the released locally biologically active molecules [17] . Moreover not uncommonly, the same types of conduits implanted to the same coronary arteries of a similar degree of stenosis manifested different patency rates and in consequences, late CABG outcomes. There are some suggestions the age of CABG patients and intrinsic venous wall viability may be of importance. However, up to now only a few studies have been focused on morphological and functional cellular variations among SMCs population in the SV segments that could potentially determine longterm outcomes of the SV aortocoronary bypass grafts [18, 19] .
This study revealed that expression of caveolins, at least cav-1 and cav-3, in the medial SMCs was associated with the age of CABG subjects. Since caveolins have played a crucial role in membrane trafficking, lipid intracellular metabolism, regulation of calcium homeostasis, lipid and signal transduction in cellular apoptosis as well as proliferation cell signaling [9, 20] , the age-dependent variations in their expression may have marked impact on late outcomes after CABG with the use of SV grafts in the agematched subgroups. Some studies published recently by our team supported the opinion that elderly patients could be particularly benefitted by the SV aortocoronary grafts [16, 18] . Among many published reports about caveolins, there are some that can provide a possible explanation of this aforementioned age-dependent phenomenon. Caveolins, particularly cav-1, have been shown to inhibit activation of the potent growth factors such as PDGF or epidermal growth factor as well as mitogen-activated protein kinase pathways [13, 21] . Thus, it is likely that higher "protective" caveolins expression in the medial SMCs of the SV may be responsible for impairing the process of the neoitima formation and as a consequence slowing the progression of venous graft disease in the elderly. Moreover, a transformation of the SMCs from contractile to synthetic phenotype observed at the early stages of arterialization of the venous grafts was associated with a loss of caveolae with caveolins [22] . Interestingly, in vitro stimulation of the SMCs with human plasma was reported to lead to their proliferation and a decrease in intracellular cav-1 expression [23] .
The hypothesis that an age-associated increase in immunostaining for caveolins in the tunica media of the SV grafts must be supported by clinical and angiographic follow up. In the future our research team plans to correlate the preexisting expression of caveolins in the SMCs to a prevalence of adverse coronary events, such as acute coronary syndromes or severe deterioration of CAD, within the late follow up period. The clinical findings will have to be confirmed with coronary angiography. Moreover, we must still wait a few years to draw final conclusions of the clinical significance of stronger caveolins' expression in the elderly because the clinical and angiographic consequences of venous grafts disease (arterialization) are seen 5 to 10 years after primary surgery [24, 25] .
CONCLUSIONS
This study revealed significant positive correlations between the expressions of cav-1 and cav-3 in the medial venous SMCs and the age of CABG patients. However, further investigations are necessary to show clinical significance of these age-related variations. 
